Balance Sheet Data

BeiGene, Ltd. (BGNE)

$194.57

+2.96 (+1.54%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 837.521,781.45982.744,650.68013,205.6124,831.1646,691.2687,795.86165,086.88
Total Cash (%)
Account Receivables 29.4352.7672.8179.67240.44452.10850.111,598.513,005.765,651.88
Account Receivables (%)
Inventories 10.9316.2428.5589.29142.20267.39502.78945.411,777.693,342.68
Inventories (%)
Accounts Payable 69.78113.28122.49231.96262.40939.721,7673,322.586,247.6111,747.69
Accounts Payable (%)
Capital Expenditure -58.73-140.84-158.61-229.03-608.37-1,143.94-2,151.01-4,044.64-7,605.34-14,300.70
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.